podophyllotoxin has been researched along with Leukemia, Myeloid, Acute in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (44.44) | 18.7374 |
| 1990's | 12 (33.33) | 18.2507 |
| 2000's | 5 (13.89) | 29.6817 |
| 2010's | 3 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annereau, JP; Bailly, C; Bonnet, D; Brel, V; Créancier, L; Currie, E; Fournier, E; Gomes, B; Guilbaud, N; Guminski, Y; Kruczynski, A; Pillon, A; Vandenberghe, I | 1 |
| Hijiya, N; Hudson, MM; Ness, KK; Ribeiro, RC | 1 |
| Annereau, JP; Bailly, C; Barret, JM; Bréand, S; Brel, V; Broussas, M; Dumontet, C; Guilbaud, N; Guminski, Y; Imbert, T; Vispé, S | 1 |
| Allard, A; Chompret, A; de Vathaire, F; Diallo, I; Haddy, N; Lassalle, M; Le Deley, MC; Lefkopoulos, D; Quiniou, E; Rubino, C; Samsaldin, A | 1 |
| Langebrake, C; Reinhardt, D; Ritter, J | 1 |
| Hanada, S; Otsuka, M; Owatari, S; Takeshita, T; Uozumi, K | 1 |
| Abramson, DH; Antoneli, CB; Bornfeld, N; Chantada, G; Dunkel, IJ; Gombos, DS; Greenwald, M; Haik, BG; Hungerford, J; Kingston, J; Leal, CA; Medina-Sanson, A; Schefler, AC; Veerakul, G; Wieland, R; Wilson, MW; Yu, CB | 1 |
| Evans, JP; Prentice, HG | 1 |
| DeBellis, R; Kasdorf, H; Schiffer, CA; Wiernik, PH | 1 |
| Baehner, R; Chard, R; Hammond, D; Higgins, G; Movassaghi, N; Pyesmany, A; Sather, H | 1 |
| Catovsky, D; Galton, DA; Goldman, JM; Islam, A | 1 |
| Bennett, JM; Cassileth, PA; Glick, JH; Lymann, GH; Oken, MM | 1 |
| Aisner, J; Van Echo, DA; Wiernik, PH | 1 |
| Apostolopoulou, E; Moschopoulos, N; Papakostas, P; Samelis, GF; Stathopoulos, GP | 1 |
| Kamen, BA; Weitman, SD; Winick, NJ | 1 |
| Kobayashi, K; Ratain, MJ | 1 |
| Kumar, L | 1 |
| Rubinstein, L; Smith, MA; Ungerleider, RS | 1 |
| Gieseler, F; Glasmacher, A; Kämpfe, D; Kunze, J; Nuessler, V; Valsamas, S; Wandt, H; Wilms, K | 1 |
| Fukuda, H; Hyouchi, N; Ishiwata, D; Kamai, T; Masuda, H; Okuno, T; Tachibana, Y; Touma, T; Yonese, J | 1 |
| Goto, T; Kozuru, M; Kumagawa, M; Muta, K; Suehiro, Y; Uike, N | 1 |
| Andreeff, M; Beran, M; Estey, E; Kantarjian, H; Keating, M; Koller, CA; Kornblau, SM; O'Brien, S | 1 |
| Bowman, LC; Brenner, MK; Hale, GA; Heslop, HE; Krance, RA; Pui, CH; Rochester, RA | 1 |
| Amylon, MD; Bash, RO; Behm, FG; Camitta, B; Chen, C; Felix, CA; Kamen, BA; Pui, CH; Raimondi, SC; Relling, MV; Shuster, JJ; Winick, NJ; Woo, MH | 1 |
| Beckmann, C; Flury, R; Frei, P; Holdener, E; Jungi, WF; Senn, HJ | 1 |
| Brunner, KW; Cavalli, F; Sonntag, R | 1 |
| Alberto, P; Cavalli, F; Sauter, C; Senn, HJ | 1 |
| Pui, CH | 1 |
| Björkholm, M | 1 |
| Andersson, BS; Beran, M; Estey, EH; Silberman, L; Zwelling, LA | 1 |
| Aoki, N; Imai, Y; Murohashi, I; Nara, N; Yamashita, Y | 1 |
| Apostol, JV; Kucuk, O | 1 |
| Chang, TT; Chou, TC; Clarkson, BD; Colvin, M; Gandola, L; Gulati, SC; Ibrahim, SM; Vega, R; Yopp, J | 1 |
| Amiel, JL; Céoara, B; de Vassal, F; Hayat, M; Jasmin, C; Mathé, G; Oldham, R; Pouillart, P; Rosenfeld, C; Schneider, M; Schwarzenberg, L; Steresco-Musset, M; Weiner, R | 1 |
| Amiel, JL; De Vassal, F; Hayat, M; Jasmin, C; Mathé, G; Misset, JL; Musset, M; Oldham, R; Pouillart, P; Rosenfeld, C; Schneider, M; Schwarzenberg, L; Weiner, R | 1 |
| Amiel, JL; Beyer, HP; de Vassal, F; Fajbisowicz, S; Hayat, M; Jasmin, C; Mathé, G; Pouillart, P; Schneider, M; Schwarzenberg, L; Weiner, R | 1 |
8 review(s) available for podophyllotoxin and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues.
Topics: Adolescent; Adult; Child; Humans; Leukemia, Myeloid, Acute; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors | 2009 |
Minimising the long-term adverse effects of childhood leukaemia therapy.
Topics: Alkylating Agents; Anthracyclines; Antimetabolites; Antineoplastic Agents; Asparaginase; Asparagine; Cardiovascular Diseases; Child; Clinical Trials as Topic; Glucocorticoids; Gonadal Disorders; Humans; Leukemia; Leukemia, Myeloid, Acute; Osteonecrosis; Podophyllotoxin; Polyethylene Glycols; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tretinoin; Vinca Alkaloids | 2002 |
Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor?
Topics: Antineoplastic Agents, Phytogenic; Child, Preschool; Cohort Studies; Databases, Factual; Enzyme Inhibitors; Female; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Podophyllotoxin; Retinal Neoplasms; Retinoblastoma; Retrospective Studies; Time Factors; Topoisomerase II Inhibitors | 2007 |
"Above all do no harm:" horizons in pediatric oncology.
Topics: Bone Marrow Transplantation; Child; Combined Modality Therapy; Growth Substances; Humans; Leukemia, Myeloid, Acute; Medical Oncology; Mercaptopurine; Methotrexate; Pediatrics; Phenotype; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quality of Life; Recurrence; Survival Rate | 1994 |
Pharmacodynamics and long-term toxicity of etoposide.
Topics: Child; Etoposide; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Neoplasms; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Testicular Neoplasms | 1994 |
Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.
Topics: Alkylating Agents; Cell Cycle; Child; Chromosomes, Human, Pair 11; Clinical Trials as Topic; Drug Administration Schedule; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Lymphoma, Non-Hodgkin; Neoplasms, Second Primary; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Risk Factors; Topoisomerase II Inhibitors; Translocation, Genetic | 1994 |
[A case of secondary leukemia in anaplastic seminoma patient treated with long-term chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasms, Second Primary; Podophyllotoxin; Seminoma; Testicular Neoplasms | 1996 |
Etoposide and teniposide in the treatment of acute leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Leukemia, Myeloid, Acute; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1990 |
4 trial(s) available for podophyllotoxin and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Evaluation of cyclocytidine in reinduction and maintenance therapy of children with acute nonlymphocytic leukemia previously treated with cytosine arabinoside: a report from Children's Cancer Study Group.
Topics: Adolescent; Adult; Ancitabine; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Delayed-Action Preparations; Female; Humans; Infant; Injections, Intraperitoneal; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Lomustine; Male; Podophyllotoxin | 1984 |
A phase II trial of VP 16-213 in adults with refractory acute myeloid leukemia. An Eastern Cooperative Oncology Group study.
Topics: Adult; Bone Marrow; Drug Evaluation; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Podophyllotoxin | 1984 |
CECA-cyclophosphamide, etoposide, carboplatin and cytosine arabinoside--a new salvage regimen for relapsed or refractory acute myelogenous leukemia.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Humans; Leukemia, Myeloid, Acute; Podophyllotoxin; Recurrence; Remission Induction; Salvage Therapy | 1998 |
Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas.
Topics: Adolescent; Adult; Aged; Alopecia; Child; Child, Preschool; Clinical Trials as Topic; Digestive System; Drug Evaluation; Female; Glycosides; Hodgkin Disease; Humans; Injections, Intravenous; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukopenia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pleural Effusion; Podophyllotoxin; Thrombocytopenia | 1974 |
24 other study(ies) available for podophyllotoxin and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Boronic Acids; Bortezomib; Cell Proliferation; Cytarabine; Deoxycytidine; Doxorubicin; Fetal Blood; Flow Cytometry; Gemcitabine; Humans; Hydroxamic Acids; Immunoenzyme Techniques; Interleukin Receptor Common gamma Subunit; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mice, SCID; Podophyllotoxin; Pyrazines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Tumor Cells, Cultured; Vorinostat; Xenograft Model Antitumor Assays | 2013 |
A fluorescent biomarker of the polyamine transport system to select patients with AML for F14512 treatment.
Topics: Animals; Antigens, CD34; Biogenic Polyamines; Biological Transport; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Flow Cytometry; Fluorescent Dyes; Humans; Leukemia, Myeloid, Acute; Oxadiazoles; Podophyllotoxin; Spermine | 2010 |
Role of radiation dose in the risk of secondary leukemia after a solid tumor in childhood treated between 1980 and 1999.
Topics: Adolescent; Algorithms; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Bone Marrow; Case-Control Studies; Child; Child, Preschool; Dose-Response Relationship, Radiation; Female; France; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Leukemia, Radiation-Induced; Likelihood Functions; Male; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasms; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Risk Assessment | 2010 |
Two cases of secondary acute myeloid leukemia accompanying adult T-cell leukemia/lymphoma.
Topics: Acute Disease; Alkylating Agents; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Neoplasms, Second Primary; Podophyllotoxin | 2007 |
Remission induction in acute myeloid leukaemia with oral etoposide.
Topics: Administration, Oral; Aged; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged; Podophyllotoxin | 1982 |
Treatment of the blast crisis of chronic myelogenous leukemia with 5-azacitidine and VP-16-213.
Topics: Adult; Aged; Azacitidine; Drug Evaluation; Drug Therapy, Combination; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Podophyllotoxin | 1982 |
Bone marrow fibre content in acute myeloid leukaemia before and after treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Collagen; Cytarabine; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Podophyllotoxin; Primary Myelofibrosis; Reticulin; Thioguanine | 1984 |
High-dose VP 16-213 (NSC 141540) for the treatment of patients with previously treated acute leukemia.
Topics: Adult; Antineoplastic Agents; Child; Drug Evaluation; Esophagitis; Etoposide; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Nausea; Pilot Projects; Podophyllotoxin; Vomiting | 1980 |
Acute non-lymphocytic leukaemia complicating gastric cancer treated with epipodophyllotoxin containing chemotherapy and G-CSF.
Topics: Antineoplastic Combined Chemotherapy Protocols; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasms, Second Primary; Podophyllotoxin; Stomach Neoplasms | 1994 |
Epipodophyllotoxins and secondary leukaemia.
Topics: Etoposide; Humans; Leukemia, Myeloid, Acute; Neoplasms, Second Primary; Podophyllotoxin | 1993 |
Topoisomerase II activities in AML blasts and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Daunorubicin; DNA Topoisomerases, Type II; Etoposide; Humans; Hydrogen-Ion Concentration; Idarubicin; Leukemia, Myeloid, Acute; Podophyllotoxin; Precipitin Tests; Topoisomerase II Inhibitors | 1996 |
Therapy-related acute myeloid leukemia with minimal myeloid differentiation (AML-M0) associated with a t(11;19)(q23;p13.3) translocation.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chromosomes, Human, Pair 11; Cyclophosphamide; DNA-Binding Proteins; Doxorubicin; Gene Rearrangement; Histone-Lysine N-Methyltransferase; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Myeloid-Lymphoid Leukemia Protein; Podophyllotoxin; Proto-Oncogenes; Transcription Factors; Translocation, Genetic; Vincristine; Zinc Fingers | 1997 |
Bone marrow transplantation for therapy-induced acute myeloid leukemia in children with previous lymphoid malignancies.
Topics: Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Female; Humans; Infant; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Podophyllotoxin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation Conditioning; Treatment Outcome | 1999 |
Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid malignancies.
Topics: Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Genotype; Glutathione Transferase; Humans; Leukemia, Myeloid, Acute; Male; Mixed Function Oxygenases; Neoplasms, Second Primary; Podophyllotoxin; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; United States | 2000 |
[Therapeutic experiences using the new podophyllotoxin derivative VP 16-213 in malignant human tumors].
Topics: Adenocarcinoma; Bronchial Neoplasms; Carcinoma; Carcinoma, Small Cell; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Prostatic Neoplasms; Remission, Spontaneous | 1975 |
Letter: Epipodophyllotoxin VP 16213 in acute non-lymphoblastic leukaemia.
Topics: Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Leukemia, Myeloid, Acute; Podophyllotoxin; Thioguanine; Vincristine | 1975 |
[The treatment of acute myelocytic leukemia during the first recurrence by means of a new cytostatic combination].
Topics: Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Leukemia, Myeloid, Acute; Podophyllotoxin; Thioguanine; Vincristine | 1976 |
Epipodophyllotoxin-related acute myeloid leukaemia.
Topics: Child; Drug Administration Schedule; Humans; Leukemia, Myeloid, Acute; Podophyllotoxin | 1991 |
The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells t
Topics: Amsacrine; Animals; Cell Line; Cell Nucleus; Crithidia; DNA; DNA Topoisomerases, Type II; Humans; Kinetics; Leukemia, Myeloid, Acute; Podophyllotoxin | 1987 |
Comparative effects of vinca alkaloids (VCR, VDS) and epipodophyllotoxin (VP16) on murine myeloblastic leukaemia.
Topics: Animals; Cell Line; Cell Survival; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Granulocytes; Leukemia, Myeloid, Acute; Macrophages; Mice; Podophyllotoxin; Tumor Stem Cell Assay; Vincristine; Vindesine | 1987 |
Amsacrine and etoposide induced paralytic ileus in a patient with acute myelomonocytic leukemia.
Topics: Aged; Aminoacridines; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Leukemia, Myeloid, Acute; Male; Podophyllotoxin | 1985 |
Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Computers; Cyclophosphamide; Drug Synergism; Etoposide; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Podophyllotoxin | 1985 |
[Acute leukemia and various hematosarcomas. Trial treatment with a second derivative of podophyllotoxin (4-demethyl-epipodophyllotoxin beta D ethylidene glucoside VP 16213 or EPE)].
Topics: Adolescent; Adult; Aged; Agranulocytosis; Alopecia; Child; Child, Preschool; Female; Hodgkin Disease; Humans; Infant; Leukemia; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Lymphatic Diseases; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Thrombocytopenia | 1974 |
[Clinical trial of chemotherapeutic combinations based on the notion of attempted cellular synchronization. Preliminary administration of an antimitotic followed by the use of cycle-dependent or phase dependent product(s)].
Topics: Amino Sugars; Anthraquinones; Antineoplastic Agents; Asparaginase; Cyclophosphamide; Daunorubicin; DNA; Drug Combinations; Drug Tolerance; Female; Hodgkin Disease; Humans; Hydroxyurea; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Mitosis; Neoplasm Metastasis; Neoplasms; Plants, Medicinal; Plants, Toxic; Podophyllum; Prednisone; Prognosis; Time Factors | 1972 |